Skip to main content
. 2010 Aug 24;103(7):1048–1056. doi: 10.1038/sj.bjc.6605840

Figure 4.

Figure 4

Kaplan–Meier curves of cohort C (second validation cohort) showing DFS (A) and OAS (B) in groups 1–3 and the HER2-positive group classified by their HER2, ER, OPN and ALCAM expression levels as follows: HER2 pos., HER2-positive tumours; group 1: HER2-negative/ER-positive tumours; group 2: ER/HER2-negative, OPN-high, ALCAM-low tumours (high-risk group); group 3: ER/HER2-negative, OPN-low tumours or OPN-high/ALCAM-high tumours.